MA H3877

Bill

MA H3877

Relative to capping the price of life saving prescription drugs

Introduced
06/13/2019

In Committee
06/13/2019

Crossed Over

Passed

Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

Relative to the cost of certain life saving prescription drugs, so-called. Financial Services.

AI Summary

This bill aims to cap the price of life-saving prescription drugs. It requires the Massachusetts Health Policy Commission to establish a maximum cost-sharing amount for each life-saving prescription drug. The bill then prohibits various state-regulated health plans, including the Group Insurance Commission, MassHealth, and private insurers, from requiring enrollees to pay more than the maximum cost-sharing amount for these critical medications. The goal is to make essential drugs more affordable and accessible for patients who need them to save their lives.

Committee Categories

Business and Industry

Sponsors (19)

Ruth Balser (D), Pete Capano (D), Jo Comerford (D), William Crocker (R), David DeCoste (R), Carolyn Dykema (D), Lori Ehrlich (D), Jamie Eldridge (D), Kim Ferguson (R), Stephen Hay (D), Natalie Higgins (D), David LeBoeuf (D), Mike Moore (D), Denise Provost (D), Lindsay Sabadosa (D), Theodore Speliotis (D), Alyson Sullivan (R), Dean Tran (R), Timothy Whelan (R),

Last Action

Accompanied a study order, see H5160 (on 12/01/2020)

Official Document

https://malegislature.gov/Bills/191/H3877

(10 Companion Bills)

Version:

Document Type	Source Location
State Bill Page	https://malegislature.gov/Bills/191/H3877
Bill	https://malegislature.gov/Bills/191/H3877.pdf

Bill	Bill Name	Last Action	Type
H4017	Relative to hospital access to discounted prescription drug prices	Signed by the Governor, Chapter 82 of the Acts of 2019	Similar To
H5160	Study Order - payments and insurance	Discharged to the committee on House Rules	Replaced by
S1149	Strengthening prescription drug safety and drug stewardship	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To
S1277	Relative to the prescription monitoring program	Accompanied a study order, see S2683	Similar To
S2397	Relative to pharmaceutical access, costs and transparency	Reprinted as amended, see S2409	Similar To
S2409	Relative to pharmaceutical access, costs and transparency	Read; and referred to the committee on House Ways and Means	Similar To
S552	To promote transparency in prescription drug prices	Accompanied a study order, see S2543	Similar To
S570	Relative to out-of-pocket expenses for prescription drug coverage	Accompanied a study order, see S2543	Similar To
S582	Ensuring access to medications	Accompanied a study order, see S2543	Similar To
S721	Relative to mandatory prescription drug coverage	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To

Bill > H3877

summary

Introduced Session

Bill Summary

AI Summary

Committee Categories

Sponsors (19)

Last Action

Official Document

bill text

bill summary

bill summary

bill summary